| | | | Index Performance | | Index | Sensex | Nifty | | Open | 15,694.41 | 4,779.95 | | High | 16,249.46 | 4,917.10 | | Low | 15,573.03 | 4,708.30 | | Today's Cls | 16,153.66 | 4,879.65 | | Prev Cls | 15,807.64 | 4,777.80 | | Change | 346.02 | 101.85 | | % Change | 2.19 | 2.13 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Bombay Dyeing | 690.05 | 13.76 | | MMTC | 26,847.80 | 10.00 | | Essar Oil | 261.95 | 8.65 | | Ranbaxy | 481.80 | 8.62 | | TCS | 975.10 | 7.37 | | Losers | | Zee Enter | 230.35 | -3.92 | | Gujarat NRE Coke | 151.55 | -3.75 | | India Cements | 177.15 | -3.49 | | Max India | 167.80 | -3.48 | | Cairn India | 244.90 | -3.11 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,784 | 832 | | Declines | 875 | 357 | | Unchanged | 50 | 34 | | Volume(Nos) | 32.87cr | 52.50cr | | | | | | Market Commentary | | | Market rebounds, scales above 16,150 | | The market bounced back into green in noon trades and scaled above 16,150 at close on a broad-based rally. | | The market witnessed a dramatic turnaround in early noon trades, as a change of guard from lower levels helped the index scale above 16,150 at close and clock | | | | gains of more than 340 points after the second session of the trading. The Sensex in the first half however traded exactly the opposite of what it did in the second half. It resumed 114 points lower at 15,694 and shed another 121 points to slip below the 15,600 mark and touch the day's low of 15,573 amid weak US and Asian markets. While the market languished in negative territory and was on a recovery mode thereafter, the index rolled back into green in noon trades and surged to an intra-day high of 16,249 on fresh buoyancy in heavyweights, IT, Technology and health care stocks. The Sensex finally signed off the session with gains of 2.19% or 346 points at 16,154, while the Nifty advanced 2.13% or 102 points to close at 4,880. | | | Movers & Shakers | - Larsen & Toubro scaled up on bagging Rs2,000-crore worth of contracts from Bombay Dying in Mumbai.
- Four Soft hit the upper circuit after winning a contract with Colvan Netherlands for implementing fright forwarding software.
- Steel Strips Wheels moved down despite bagging a repeat export order from KROMAG KFG-Austria.
- KEC International declined in spite of winning Rs155 crore-worth Power Grid Contracts in Kerala.
| | | |
The market breadth was positive. Of the 2,709 stocks traded on the BSE (Bombay Stock Exchange), 1,784 stocks advanced, 875 stocks declined and 50 stocks ended unchanged. Out of 13 sectoral indices, all indices ended higher. The BSE IT index scaled up by 5.55% followed by the BSE Teck index (up 4.08%), the BSE HC index (up 3.32%) and the BSE CD index (up 2.78%). However, the BSE Auto and the BSE Metal index ended with marginal gains.
Heavyweights spurred the late rally and notched up significant gains. Ranbaxy Laboratories soared 8.62% at Rs481.80, TCS advanced 7.37% at Rs975.10, Infosys added 6.21% at Rs1,510.80, Reliance Communications scaled up 5.38% at Rs519.80, Wipro rose 4.52% at Rs424.65 and HUL jumped 4.36% at Rs245.40. Satyam Computer, DLF, NTPC, ONGC, ICICI Bank, RIL, Cipla and Jaiprakash Associates gained over 2% each. Among the laggards Hindalco dropped 1.59% at Rs173.55, HDFC Bank lost 0.95% at Rs1,315.25, Ambuja Cement declined by 0.89% at Rs116.55, HDFC was marginally down at Rs1,264 and ACC lost 0.24% at Rs810.65.
IT stocks registered strong gains in the late rally. Mphasis advanced 7.10% at Rs226.95, HCL Technology gained 6.78% at Rs245.80. Patni Computers, I-Flex, Tech Mahindra, Rolta India and NIIT were up over 3% each. Among the Teck stocks Zee News, HFCL, WWIL, Adlabs Films, Deecan, Aptech, flared up over 1.7% each.
Over 2.27 crore RNRL shares changed hands on the BSE followed by Orchid Chemical (1.65 crore shares), RPL (1.59 crore shares), Sita Shree Food Products (1.42 crore shares) and BL Kashyap (1.33 crore shares).
Orchid Chemicals was the most actively traded counter on the BSE with a turnover of Rs453 crore followed by RIL (Rs373 crore), RPL (Rs299 crore), RNRL (Rs233 crore) and Reliance Capital (Rs196 crore).
| | | | | | | | European Indices at 16:27 IST on 15-04-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 5880.20 | 48.60 | 0.83 | | CAC 40 Index | 4746.47 | -20.02 | -0.42 | | DAX Index | 6547.51 | -6.98 | -0.11 | | | | | | | | | | | Asian Indices at close on 15-04-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 12990.58 | 73.07 | 0.57 | | Hang Seng Index | 23901.33 | 90.13 | 0.38 | | Kospi Index | 1742.17 | -4.54 | -0.26 | | Straits Times Index | 3056.49 | 13.53 | 0.44 | | Jakarta Composite Index | 16153.66 | 346.02 | 2.19 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
